Company Description
Ark Therapeutics PLC. The Group's principal activity is discovering, developing and commercialising products in areas of specialise medicine with particular focus on vascular disease and cancer. The Group product brands include Cerepro, Vitor, ...
Related Business Topics
Breaking News
Forbes.com - November 10, 2009 11:46 PM
LONDON, Nov 11 (Reuters) - Ark Therapeutics Group Plc: * Since H1 cash consumption has been in line and continues to manage cost base carefully * Continued to progress the realisation of value from stroke patent in Europe ((London ...
Reuters - October 14, 2009 3:32 PM
Funds to Assist Those Impacted by Droughts in Guatemala, Flooding in Southern India and Natural Disasters throughout Southeast Asia BENTONVILLE, Ark., Oct. 14 /PRNewswire-FirstCall/ -- The Walmart Foundation announced today a donation of $350,000 in ...
Forbes.com - October 14, 2009 12:53 AM
LONDON, Oct 14 (Reuters) - Ark Therapeutics Group Plc: * Further Cerepro Phase III results to be presented at American Society of Neuro-Oncology conference in ...
Forbes.com - September 04, 2009 12:49 AM
LONDON, Sept 4 (Reuters) - Ark Therapeutics Group Plc: * Receives positive feedback from MHRA scientific advice meeting on EG013 for foetal growth restriction * MHRA concluded that the choice of species and overall design of the pre-clinical toxicology ...
